Semaglutide is a GLP-1 drug taken weekly by pen or daily by tablet; Wegovy is the weight brand and Ozempic the type 2 diabetes brand.
An older island, so Medicare comes first
Roughly a fifth of Long Islanders are 65 or older: 20.5% in Nassau and 20.1% in Suffolk [5][6]. Part D members who meet the BMI and health tests can get Wegovy pens or tablets for $50 a month under the Medicare GLP-1 Bridge, which runs July 1, 2026 to December 31, 2027 [7][8]. Ozempic and Zepbound vials do not qualify [8]. Diagnosed diabetes sits near 10% of adults in both counties [3][4].
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Long Island, from $300 a month.
A practice paid for the labeled spot above; that does not make it our recommendation.
Self-pay semaglutide prices
| Product | Price | Who can use it | Source |
|---|---|---|---|
| Wegovy pen | $349/month; $199 first two low-dose fills | Self-pay, new patients for the $199 offer | [1] |
| Wegovy pill | $149 to $299/month | Self-pay | [1] |
| Ozempic | $349/month; $499 for 2 mg | Self-pay, type 2 diabetes | [2] |
| Wegovy via Medicare GLP-1 Bridge | $50/month copay | Eligible Part D members | [7] |
More detail: semaglutide cost, GLP-1s and Medicare and Ozempic vs Wegovy.
What the drug costs against local incomes
Nassau's median household income is $146,202 and Suffolk's is $130,686 [5][6]. Twelve months of Wegovy pens at $349 total $4,188 [1], close to 3% of either figure. Many households here have job-based insurance; if it covers Wegovy, Novo's copay card can bring a month down to $25 [1].
Trial results and side effects, in short
STEP 1 reported a 14.9% average weight loss at 68 weeks on 2.4 mg (placebo: 2.4%) [9], and the Wegovy label's most common complaints are gut-related, led by nausea at 44% [10]. In a follow-up, people who stopped had regained about two-thirds of the loss within a year [11]; see stopping semaglutide and the full list on semaglutide side effects.
Get help for these
Rodent studies linked semaglutide to thyroid C-cell tumors, hence the boxed warning. Belly pain that is intense and lasting (possible pancreatitis), allergic swelling, or lows while also on insulin or a sulfonylurea all need prompt care. Come off it 2 months or more before trying to conceive [10]. Dial 911 in an emergency.
Compounded vials and NY license lookups
Compounded semaglutide has no FDA approval, and FDA does not vet it for safety, effectiveness or quality; it has warned of dosing mistakes with compounded vials that sent people to the hospital [12]. New York physicians can be looked up through the NYS Office of the Professions [13]. See compounded semaglutide and the FDA letter tracker.
Nearby pages
Semaglutide in NYC, New Jersey, Baltimore, Long Island weight loss, semaglutide near me and the semaglutide guide.
Questions people ask
Do Nassau and Suffolk residents pay more for Wegovy than other New Yorkers?
No. NovoCare's cash price is national: $349 a month for the pen and $149 to $299 for tablets on October 17, 2026 [1].
Can a Long Island Medicare member get Wegovy for $50 a month?
Is Ozempic part of the Medicare GLP-1 Bridge?
No. CMS limits the Bridge to Wegovy, Foundayo and the Zepbound KwikPen [8].
What share of Nassau and Suffolk adults have diabetes?
Will New York Medicaid pay for semaglutide for weight loss?
No. New York was not among the Medicaid programs KFF listed as covering obesity GLP-1s in January 2026 [14].
Where can I check a Long Island prescriber's license?
The NYS Education Department's Office of the Professions licenses physicians in New York [13].
Which Wegovy side effect is most common?
Nausea, reported by 44% of adults on 2.4 mg in the label's trials; diarrhea (30%), vomiting (24%) and constipation (24%) followed [10].
Sources
14 cited
- Wegovy self-pay offer. Novo Nordisk (NovoCare), accessed 2026-10-17.
- Ozempic self-pay pricing. Novo Nordisk (NovoCare), accessed 2026-10-17.
- PLACES county estimates: Nassau County, NY. CDC PLACES (2025 release, BRFSS 2023), 2025 release.
- PLACES county estimates: Suffolk County, NY. CDC PLACES (2025 release, BRFSS 2023), 2025 release.
- QuickFacts: Nassau County, New York. U.S. Census Bureau, V2025 estimates, accessed 2026-10-17.
- QuickFacts: Suffolk County, New York. U.S. Census Bureau, V2025 estimates, accessed 2026-10-17.
- Weight loss drugs coverage. Medicare.gov, accessed 2026-10-17.
- Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, accessed 2026-10-17.
- Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine (PubMed), Feb 10, 2021.
- Wegovy label. DailyMed, NLM, Jun 2026.
- Weight regain after withdrawal of semaglutide (STEP 1 extension). Diabetes, Obesity and Metabolism (PubMed), May 19, 2022.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
- New York State Board for Medicine. NYS Education Department, Office of the Professions, accessed 2026-10-17.
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.